Here is the latest stock price and chart of Aurobindo Pharma. For more details, see the Aurobindo Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
EXPIRES at 11:59pm: Full Transcript of Our Urgent Broadcast on India's Revival
Live BSE Quotes | Apr 19, 2021 (Close) | ||
---|---|---|---|
Price (Rs)965.50 | Open (Rs) 952.00 | High (Rs) 973.00 | Low (Rs) 933.00 |
% Change1.31 | Volume 146,090 | Value (Rs) 139,452,569 | 52-Week H/L 1,023.10 / 525.05 |
Live NSE Quotes | Apr 19, 2021 (Close) | ||
---|---|---|---|
Price (Rs)965.90 | Open (Rs) 955.00 | High (Rs) 974.00 | Low (Rs) 932.20 |
% Change1.35 | Volume 4,587,771 | Value (Rs) 4,383,524,616 | 52-Week H/L 1,023.70 / 525.50 |
Change | |||||
---|---|---|---|---|---|
1 Day 1.31% | 1 Month 17.26% | 3 Months 4.52% | 1 Year 78.61% | 5 Years (CAGR)* 4.59% | 10 Years (CAGR)* 25.85% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 51.38 | P/E Ratio (x) 18.79 | Market Cap (Rs m) 564,980.67 | P/BV (x) 4.07 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
![]() |
||
S&P BSE SENSEX ![]() |
||||||
PERIOD |
AUROBINDO PHARMA last traded price was up 1.3% to Rs 965.5 on the BSE. On the NSE, AUROBINDO PHARMA last traded price was up 1.4% to Rs 965.9. The total volume of shares traded was 4.7 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.4%. And the benchmark S&P BSE SENSEX was at 47,949.4 (down 1.8%).
Over the last 30 days, the AUROBINDO PHARMA share price is up 14.8%. And over the last one year, AUROBINDO PHARMA share price is up 77.0%.
What else is happening in the markets today? Dig in...
Indian share markets nosedived and registered sharp losses in today's volatile session following a strong second wave of Covid-19 in the country.
For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.
For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.
Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More